Literature DB >> 2413448

Insertion of the bacterial gpt gene into the germ line of mice by retroviral infection.

D Jähner, K Haase, R Mulligan, R Jaenisch.   

Abstract

Mouse substrains genetically transmitting the exogenous Moloney murine leukemia virus (Mo-MuLV) at a single locus have been derived previously by infection of preimplantation embryos. Here we explore the potential of retroviral vectors for transferring nonviral genes into the germ line of mice. Preimplantation mouse embryos were cocultivated with a cell line that produces a recombinant retrovirus whose genome carries the Escherichia coli gene gpt. We show that the vector sequence was inserted into the genome of the embryo and into the germ line at a frequency similar to that for the Mo-MuLV-helper sequence. A new mouse strain, Mgpt-1, was developed that is homozygous for a single MSVgpt proviral genome. The proviral sequences were highly methylated and not expressed in tissues of Mgpt-1 mice. When cells derived from transgeneic animals were treated with 5-azacytidine, the proviral sequences were not methylated and were transcriptionally activated. These results indicate that nonviral genes that are under the control of the viral long terminal repeat are inactivated when transferred into the germ line of animals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413448      PMCID: PMC390801          DOI: 10.1073/pnas.82.20.6927

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Infectious and selectable retrovirus containing an inducible rat growth hormone minigene.

Authors:  A D Miller; E S Ong; M G Rosenfeld; I M Verma; R M Evans
Journal:  Science       Date:  1984-09-07       Impact factor: 47.728

2.  Retrovirus-induced lethal mutation in collagen I gene of mice is associated with an altered chromatin structure.

Authors:  M Breindl; K Harbers; R Jaenisch
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

3.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

4.  Construction of a retrovirus capable of transducing and expressing genes in multipotential embryonic cells.

Authors:  J L Rubenstein; J F Nicolas; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

5.  Integration-specific retrovirus expression in embryonal carcinoma cells.

Authors:  J Sorge; A E Cutting; V D Erdman; J W Gautsch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

7.  Introduction of a selectable gene into different animal tissue by a retrovirus recombinant vector.

Authors:  H Stuhlmann; R Cone; R C Mulligan; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range.

Authors:  R D Cone; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

9.  Structural and functional organization of the gpt gene region of Escherichia coli.

Authors:  J Nüesch; D Schümperli
Journal:  Gene       Date:  1984-12       Impact factor: 3.688

10.  Transfer of genes into embryonal carcinoma cells by retrovirus infection: efficient expression from an internal promoter.

Authors:  E F Wagner; M Vanek; B Vennström
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  19 in total

1.  Inoculation of newborn SWR/J females with an ecotropic murine leukemia virus can produce transgenic mice.

Authors:  J J Panthier; H Condamine; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Modulation of gene expression in multiple hematopoietic cell lineages following retroviral vector gene transfer.

Authors:  M C Magli; J E Dick; D Huszar; A Bernstein; R A Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  Expression of human adenosine deaminase in murine hematopoietic cells.

Authors:  J W Belmont; G R MacGregor; K Wager-Smith; F A Fletcher; K A Moore; D Hawkins; D Villalon; S M Chang; C T Caskey
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

4.  Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells.

Authors:  H Weiher; E Barklis; W Ostertag; R Jaenisch
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

Review 5.  Germ-line transformation of mice.

Authors:  R D Palmiter; R L Brinster
Journal:  Annu Rev Genet       Date:  1986       Impact factor: 16.830

6.  Activator-dependent and activator-independent defective recombinant retroviruses from bovine leukemia virus.

Authors:  D Milan; J F Nicolas
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

7.  Expression of transduced genes in mice generated by infecting blastocysts with avian leukosis virus-based retroviral vectors.

Authors:  M J Federspiel; D A Swing; B Eagleson; S W Reid; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 8.  Transgenic and knockout mice in the study of neurodegenerative diseases.

Authors:  A Aguzzi; S Brandner; S Marino; J P Steinbach
Journal:  J Mol Med (Berl)       Date:  1996-03       Impact factor: 4.599

9.  Generation of transgenic mice.

Authors:  Andrew Cho; Naoto Haruyama; Ashok B Kulkarni
Journal:  Curr Protoc Cell Biol       Date:  2009-03

10.  Retroviral-mediated transfer of genomic globin genes leads to regulated production of RNA and protein.

Authors:  S Karlsson; T Papayannopoulou; S G Schweiger; G Stamatoyannopoulos; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.